Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brody

Showing results (501-510 of 517) with videos related to

Pageof 52
Sort By:
Cancer Research Communications|May 21, 2026
Increased glucose availability sensitizes pancreatic cancer to macrophage-targeting immunotherapiesJonathan J Hue, Mehrdad Zarei, Priyashree Sunita, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
Oncogene|May 28, 2013
Targeting cell cycle and hormone receptor pathways in cancerC E S Comstock, M A Augello, J F Goodwin, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
Proceedings of the American Thoracic Society|September 2, 2008
Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and functionTeri J Franks, Thomas V Colby, William D Travis, et al.
Future Oncology (London, England)|October 8, 2024
CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancerCharles D Lopez, Adel Kardosh, Emerson Y Chen, et al.
Nature Communications|June 28, 2023
Increased glucose availability sensitizes pancreatic cancer to chemotherapyAli Vaziri-Gohar, Jonathan J Hue, Ata Abbas, et al.
Cancer Research|July 6, 2019
Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic CancerAditi Jain, Lebaron C Agostini, Grace A McCarthy, et al.
Cancers|February 10, 2024
Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical RecommendationsAmber N Habowski, Deepthi P Budagavi, Sandra D Scherer, et al.
Molecular Cancer Therapeutics|August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the MitochondriaChristopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
Pageof 52

Showing results (501-510 of 517) with videos related to

Sort By:
Pageof 52
Cancer Research Communications|May 21, 2026
Increased glucose availability sensitizes pancreatic cancer to macrophage-targeting immunotherapiesJonathan J Hue, Mehrdad Zarei, Priyashree Sunita, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
Oncogene|May 28, 2013
Targeting cell cycle and hormone receptor pathways in cancerC E S Comstock, M A Augello, J F Goodwin, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
Proceedings of the American Thoracic Society|September 2, 2008
Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and functionTeri J Franks, Thomas V Colby, William D Travis, et al.
Future Oncology (London, England)|October 8, 2024
CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancerCharles D Lopez, Adel Kardosh, Emerson Y Chen, et al.
Nature Communications|June 28, 2023
Increased glucose availability sensitizes pancreatic cancer to chemotherapyAli Vaziri-Gohar, Jonathan J Hue, Ata Abbas, et al.
Cancer Research|July 6, 2019
Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic CancerAditi Jain, Lebaron C Agostini, Grace A McCarthy, et al.
Cancers|February 10, 2024
Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical RecommendationsAmber N Habowski, Deepthi P Budagavi, Sandra D Scherer, et al.
Molecular Cancer Therapeutics|August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the MitochondriaChristopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
Pageof 52